Table II.
Overall survival univariate | OS multivariate | Disease-free survival univariate | DFS multivariate | |||||
HR (95%CI) | pa | HR (95%CI) | pa | HR (95%CI) | pa | HR (95%CI) | Pa | |
---|---|---|---|---|---|---|---|---|
miR-888 | ||||||||
Low | – | – | – | – | ||||
High | 5.42 (3.69, 11.55) | 0.005a | 4.89 (2.44, 9.08) | 0.008a | 6.01 (2.85, 11.75) | 0.018a | 5.37 (2.96, 10.03) | 0.011a |
Age | ||||||||
<60 | – | – | – | |||||
≥60 | 1.72 (1.11, 2.93) | 0.290 | 1.56 (1.07, 2.67) | 0.345 | ||||
Sex | ||||||||
Female | – | – | ||||||
Male | 1.42 (1.02, 1.99) | 0.284 | 1.28 (0.96, 1.85) | 0.368 | ||||
Tumor location | ||||||||
Transverse | – | – | ||||||
Right | 0.85 (0.55, 1.34) | 0.523 | 0.81 (0.49, 1.28) | 0.673 | ||||
Left | 1.16 (0.91, 1.66) | 0.301 | 1.07 (0.85, 1.50) | 0.455 | ||||
pT status | ||||||||
T1/T2 | – | – | – | – | ||||
T3/T4 | 2.60 (1.17, 4.36) | 0.025a | 2.11 (1.01, 4.22) | 0.036a | 2.28 (1.25, 4.64) | 0.017a | 1.98 (1.12, 3.87) | 0.024a |
pN status | ||||||||
Absent | – | – | – | – | ||||
Present | 3.18 (2.03,7.67) | 0.003a | 2.88 (1.21,4.70) | <0.001a | 3.03 (2.43, 7.07) | 0.004a | 2.78 (1.27, 5.45) | 0.011a |
pM status | ||||||||
Absent | – | – | – | – | ||||
Present | 5.21 (2.42,10.61) | 0.023a | 4.98 (2.33,9.75) | 0.037a | 5.75 (2.21,10.87) | 0.028a | 5.18 (2.08,9.15) | 0.033a |
AJCC stage | ||||||||
I/II | – | – | – | – | ||||
III/IV | 4.12 (2.37,8.86) | 0.009a | 3.82 (1.55,6.71) | 0.011a | 4.92 (2.49,9.19) | 0.024a | 3.37 (1.43, 6.77) | 0.031a |
Differentiation | ||||||||
Well | – | – | – | – | ||||
Moderate | 3.59 (1.02, 6.12) | 0.023a | 2.54 (1.35,4.71) | 0.017a | 3.03 (1.25, 5.66) | 0.008a | 2.69 (1.09, 4.96) | 0.013a |
Poor | 5.45 (2.22,12.34) | <0.001a | 4.76 (2.29,11.23) | 0.004a | 5.75 (2.41,11.63) | 0.019a | 5.08 (2.83, 10.21) | 0.005a |
HR, hazard ratio; CI, confidence interval.
Statistically significant.